Chronische lymphatische Leukämie/lymphoplasmozytoides Lymphom
作者： M. Hallek , B. Emmerich
DOI: 10.1007/3-540-31303-6_173
关键词:
摘要: Die DCLLSG hat eine alters-, komorbiditats- und risikoadaptierte Strategie fur die Primartherapie der CLL entwickelt (Abb. 3). Protokolle reflektieren den aktuellen Kenntnisstand im Sinne einer alters- risikoangepasten Vorgehensweise in Behandlung von CLL-Patienten.
springer.com
sci-hub.st 参考文章(101)
Nancy Bartlett, D. L. Longo, T-small lymphocyte disorders Seminars in Hematology. ,vol. 36, pp. 164- 170 ,(1999)
Daniela Lens, Pierre J.J.C. De Schouwer, Rifat A. Hamoudi, Munah Abdul-Rauf, Nahla Farahat, Estella Matutes, Tim Crook, Martin J.S. Dyer, Daniel Catovsky, p53 abnormalities in B-cell prolymphocytic leukemia. Blood. ,vol. 89, pp. 2015- 2023 ,(1997) , 10.1182/BLOOD.V89.6.2015
Francesca R. Mauro, Robert Foa, Diana Giannarelli, Iole Cordone, Sabrina Crescenzi, Edoardo Pescarmona, Roberta Sala, Raffaella Cerretti, Franco Mandelli, Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood. ,vol. 94, pp. 448- 454 ,(1999) , 10.1182/BLOOD.V94.2.448
BD Cheson, JM Bennett, M Grever, N Kay, MJ Keating, S O'Brien, KR Rai, National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment Blood. ,vol. 87, pp. 4990- 4997 ,(1996) , 10.1182/BLOOD.V87.12.4990.BLOODJOURNAL87124990
MJ Keating, H Kantarjian, M Talpaz, J Redman, C Koller, B Barlogie, W Velasquez, W Plunkett, EJ Freireich, KB McCredie, Fludarabine: a new agent with major activity against chronic lymphocytic leukemia Blood. ,vol. 74, pp. 19- 25 ,(1989) , 10.1182/BLOOD.V74.1.19.19
E Matutes, V Brito-Babapulle, J Swansbury, J Ellis, R Morilla, C Dearden, A Sempere, D Catovsky, Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood. ,vol. 78, pp. 3269- 3274 ,(1991) , 10.1182/BLOOD.V78.12.3269.3269
B. Emmerich, M. Hallek, I. Kuhn-Hallek, Prognostic factors in chronic lymphocytic leukemia. Leukemia. ,vol. 11, ,(1997)
M.J. Keating, S. O’Brien, S. Lerner, C. Koller, M. Beran, L.E. Robertson, E. J Freireich, E. Estey, H. Kantarjian, Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood. ,vol. 92, pp. 1165- 1171 ,(1998) , 10.1182/BLOOD.V92.4.1165
Jan A. Burger, Meike Burger, Thomas J. Kipps, Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood. ,vol. 94, pp. 3658- 3667 ,(1999) , 10.1182/BLOOD.V94.11.3658
Ian W. Flinn, John C. Byrd, Candis Morrison, Janet Jamison, Louis F. Diehl, Timothy Murphy, Steve Piantadosi, Eric Seifter, Richard F. Ambinder, Georgia Vogelsang, Michael R. Grever, Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies. Blood. ,vol. 96, pp. 71- 75 ,(2000) , 10.1182/BLOOD.V96.1.71.013K21_71_75